ISOTYPE CHARACTERIZATION OF ANTI-INFLIXIMAB ANTIBODIES IN PEDIATRIC PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INFLIXIMAB

被引：0
|
作者：
Kosmac, M. [1 ,2 ,3 ]
Toplak, N. [3 ]
Simonini, G. [4 ,5 ]
Cimaz, R. [4 ,5 ]
Serbec, V. Curin [1 ,2 ]
Avcin, T. [3 ]
机构：
[1] Blood Transfus Ctr Slovenia, Dept Prod Diagnost Reagents & Res, Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 61000, Slovenia
[3] Univ Childrens Hosp, Univ Med Ctr, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia
[4] Anna Meyer Childrens Hosp, Rheumatol Unit, Florence, Italy
[5] Univ Florence, Florence, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2260
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：255 / 255
页数：1
相关论文
共 50 条
  • [31] METHOTREXATE REDUCED TNF BIOACTIVITY BY ANTI-INFLIXIMAB ANTIBODY PREVENTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB
    Denarie, D.
    Rinaudo, M.
    Thomas, T.
    Paul, S.
    Marotte, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 459 - 459
  • [32] Quantum blue anti-infliximab: development and evaluation of a point of care rapid test for measuring anti-infliximab antibodies in human serum
    Bantleon, F.
    Schneider, M.
    Ricken, B.
    Velayutham, S.
    Trapani, D.
    Afonso, J.
    Magro, F.
    Abel, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S194 - S195
  • [33] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    van der Maas, Aatke
    van den Bemt, Bart J. F.
    Wolbink, Gertjan
    van den Hoogen, Frank H. J.
    van Riel, Piet L. C. M.
    den Broeder, Alfons A.
    BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [34] INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES COMPARISON BETWEEN TWO COMERCIAL ELISA VERSIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Hernandez Florez, D.
    Valor, L.
    Nieto, J. C.
    Martinez, L.
    de la Torre, I.
    del Rio, T.
    Gonzalez, C.
    Lopez-Longo, J.
    Monteagudo, I.
    Naredo, E.
    Montoro, M.
    Carreno Perez, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 715 - 716
  • [35] ESTABLISHING CUT-OFF OF INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES BY COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hernandez, Diana
    Valor, Lara
    de la Torre, Inmaculada
    Martinez, Lina
    Carlos Nieto, Juan
    del Rio, Tamara
    Naredo, Esperanza
    Gonzalez, Carlos
    Lopez-Longo, Javier
    Montoro, Maria
    Monteagudo, Indalecio
    Carreno, Luis
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A11 - A11
  • [36] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    Aatke van der Maas
    Bart JF van den Bemt
    Gertjan Wolbink
    Frank HJ van den Hoogen
    Piet LCM van Riel
    Alfons A den Broeder
    BMC Musculoskeletal Disorders, 13
  • [37] POINT-OF-CARE MONITORING OF ANTI-INFLIXIMAB ANTIBODIES IN PATIENTS TREATED WITH THE REFERENCE INFLIXIMAB OR CT-P13 IN ROUTINE CLINICAL PRACTICE
    Ametzazurra, A.
    Rivera, N.
    Balsa, A.
    Arreba, M. P.
    Ruiz, E.
    Plasencia, C.
    Ortiz, J.
    Pascual-Salcedo, D.
    Munoz, M. C.
    De Aysa, C.
    Allande, M. J.
    Torres, N.
    Hernandez, A. M.
    Recalde, X.
    Martinez, A.
    Nagore, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 555 - 555
  • [38] Identification of a cut-off for persistent anti-infliximab antibodies as a predictor of response to infliximab monotherapy
    Del Nero, L.
    Bodini, G.
    Giannini, E.
    Anjali, J.
    Savarino, V.
    Savarino, E.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S270 - S271
  • [39] IDENTIFICATION OF A CUT-OFF FOR PERSISTENT ANTI-INFLIXIMAB ANTIBODIES AS A PREDICTOR OF RESPONSE TO INFLIXIMAB MONOTHERAPY
    Del Nero, L.
    Bodini, G.
    Giannini, E. G.
    Savarino, V
    De Maria, C.
    Baldissarro, I
    Savarino, E.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E77 - E77
  • [40] Monitoring of infliximab trough levels and anti-infliximab antibodies in inflammatory bowel diseases: A comparison of three commercially available ELISA kits
    Bertin, Daniel
    Serrero, Melanie
    Grimaud, Jean Charles
    Desjeux, Ariadne
    Desplat-Jego, Sophie
    CYTOKINE, 2020, 126
12345